Pfam Domains GO Terms
| VWC |
| Collagen |
| COLFI |
| collagen type III trimer |
| aorta smooth muscle tissue morphogenesis |
| platelet-derived growth factor binding |
| negative regulation of neuron migration |
| smooth muscle tissue development |
| aorta morphogenesis |
| positive regulation of Rho protein signal transduction |
| extracellular matrix structural constituent conferring tensile strength |
| regulation of neuron migration |
| collagen fibril organization |
| aorta development |
| SMAD binding |
| peptide cross-linking |
| artery morphogenesis |
| positive regulation of Ras protein signal transduction |
| cellular response to amino acid stimulus |
| positive regulation of small GTPase mediated signal transduction |
| muscle tissue morphogenesis |
| artery development |
| muscle organ morphogenesis |
| integrin-mediated signaling pathway |
| transforming growth factor beta receptor signaling pathway |
| protease binding |
| response to amino acid |
| cerebral cortex development |
| cell-matrix adhesion |
| digestive tract development |
| integrin binding |
| extracellular matrix structural constituent |
| platelet activation |
| digestive system development |
| regulation of Rho protein signal transduction |
| negative regulation of immune response |
| cellular response to transforming growth factor beta stimulus |
| response to transforming growth factor beta |
| pallium development |
| cell-substrate adhesion |
| transmembrane receptor protein serine/threonine kinase signaling pathway |
| cellular response to acid chemical |
| response to mechanical stimulus |
| extracellular matrix |
| regulation of Ras protein signal transduction |
| telencephalon development |
| negative regulation of cell migration |
| negative regulation of cell motility |
| negative regulation of neurogenesis |
| blood coagulation |
| coagulation |
| muscle organ development |
| muscle tissue development |
| hemostasis |
| endoplasmic reticulum lumen |
| negative regulation of cellular component movement |
| negative regulation of nervous system development |
| negative regulation of locomotion |
| negative regulation of cell development |
| extracellular matrix organization |
| regulation of small GTPase mediated signal transduction |
| response to acid chemical |
| collagen-containing extracellular matrix |
| skin development |
| extracellular structure organization |
| forebrain development |
| blood vessel morphogenesis |
| response to radiation |
| negative regulation of immune system process |
| supramolecular fiber organization |
| muscle structure development |
| wound healing |
| blood vessel development |
| skeletal system development |
| regulation of body fluid levels |
| cellular response to growth factor stimulus |
| vasculature development |
| cardiovascular system development |
| heart development |
| response to growth factor |
| tissue morphogenesis |
| response to wounding |
| cellular response to organonitrogen compound |
| tube morphogenesis |
| cellular response to nitrogen compound |
| negative regulation of cell differentiation |
| enzyme linked receptor protein signaling pathway |
| brain development |
| head development |
| regulation of neurogenesis |
| tube development |
| regulation of cell migration |
| circulatory system development |
| regulation of cell motility |
| regulation of nervous system development |
| cell adhesion |
| regulation of cell development |
| biological adhesion |
| negative regulation of developmental process |
| animal organ morphogenesis |
| central nervous system development |
| regulation of locomotion |
| regulation of cellular component movement |
| response to organonitrogen compound |
| positive regulation of intracellular signal transduction |
| cellular response to oxygen-containing compound |
| cell activation |
| response to nitrogen compound |
| response to cytokine |
| regulation of immune response |
| response to abiotic stimulus |
| negative regulation of multicellular organismal process |
| cellular response to endogenous stimulus |
| response to endogenous stimulus |
| generation of neurons |
| response to oxygen-containing compound |
| extracellular space |
| negative regulation of response to stimulus |
| neurogenesis |
| regulation of immune system process |
| positive regulation of signal transduction |
| tissue development |
| regulation of cell differentiation |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of intracellular signal transduction |
| protein-containing complex subunit organization |
| extracellular region |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Azithromycin 100μM R08 exp452 | -1.83 |
| Cyclosporin-A 0.8μM R07 exp347 | -1.81 |
| LY2090314 0.003μM R08 exp500 no dilution day6 | -1.7 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution